Suchergebnisse - "Zhu, Hong-Hu"

PubPharm (200)

1

A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia : making progress in chemotherapy-free regimens

enthalten in: Hematology (Amsterdam, Netherlands) | 2024

von Xiong, Z. | Shen, Y. | Zhang, S. | +1

2

Chemo-free treatment of adult patients with Ph-positive acute lymphoblastic leukemia : latest updates from the 2023 ASH annual meeting

enthalten in: Journal of hematology & oncology | 2024

von Shi, T. | Zhu, H.

3

Chemo-free treatment of adult patients with Ph-positive acute lymphoblastic leukemia: latest updates from the 2023 ASH annual meeting

enthalten in: Journal of hematology & oncology | 2024

von Shi, T. | Zhu, H.

4

Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients : A propensity score‐matched analysis

enthalten in: Hematological Oncology | 2024

von Wang, R. | Zhang, Y. | Chang, J. | +13

5

Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients : A propensity score-matched analysis

enthalten in: Hematological oncology | 2024

von Wang, R. | Zhang, Y. | Chang, J. | +13

6

A geotechnical perspective on soil-termite interaction : Role of termites in unsaturated soil properties

enthalten in: The Science of the total environment | 2023

von Garg, A. | Gadi, V. | Zhu, H. | +3

7

Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia : A single-arm, multicentre, phase 2 trial

enthalten in: British journal of haematology | 2023

von Xie, M. | Lu, Y. | Ouyang, G. | +27

8

15-days duration of venetoclax combined with azacitidine in the treatment of relapsed/refractory high-risk myelodysplastic syndromes : A retrospective single-center study

enthalten in: Hematological oncology | 2023

von Mei, C. | Ye, L. | Ren, Y. | +12

9

A global study for acute myeloid leukemia with RARG rearrangement

enthalten in: Blood advances | 2023

von Zhu, H. | Qin, Y. | Zhang, Z. | +44

10

CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease

enthalten in: Annals of hematology | 2023

von Shen, Y. | Zhang, Y. | Chang, J. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]